Physical Activity Immediately After Acute Cerebral Ischemia
NCT ID: NCT01594190
Last Updated: 2012-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
250 participants
INTERVENTIONAL
2012-09-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies in a late and stationary phase after stroke have shown that physical rehabilitation is of great importance for survival and physical ability of these patients, however many studies show that patients lie or sit next to their bed under hospitalization for more than 88.5 % of the daily hours. Physical activity in stroke patients has never previously been measured immediately after debut of symptoms; furthermore there is no knowledge about the optimal dose of physical rehabilitation for these patients.
Accelerometers, small measuring devices, are a relatively new way to measure physical activity precisely, and hence it is possible to obtain an objective measure of how active stroke patients are in the first week after admission. The accelerometers measure a variable voltage, depending on the range and intensity of movement. They can measure movement dependent of the placement of the accelerometer, for instance over the hip, arm or leg. Studies confirm their reliability, even in patients with abnormal gait, such as stroke patients.
Another approach of studying the effects of physical activity and rehabilitation is through the examination of biomarkers. Studies have shown that biomarkers released during physical activity can inhibit biomarkers released after tissue injury in the brain, as seen after stroke. These brain biomarkers cause further damage and studies show that the higher the levels, the higher the damage. It is therefore obvious to examine whether physical activity rehabilitation can down regulate this destructive process in patients with stroke.
Clarification of the optimal dose of physical activity in stroke patients immediately after debut of symptoms and examination of both the biochemical aspects of physical rehabilitation as well as the optimal dose of physical rehabilitation is of great importance for many patients, their relatives as well as of a great socioeconomic importance.
The purpose of the project is to investigate which dose (15 vs. 2 x 30 minutes) of physical activity on a weight-bearing treadmill in the first 5 days after admission after an ischemic stroke, gives patients the best improvement in neurological dysfunction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity Immediately After Acute Cerebral Ischemia
NCT01560520
Physical Activity Immediately After Acute Cerebral Ischemia 3
NCT01712282
Pre-stroke Physical Activity in Patients With Stroke
NCT05051111
The Effect of Aerobic Exercise in Patients With Lacunar Stroke
NCT02731235
MONitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
NCT05793177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Dose Training
15 minutes/day on a weight-bearing treadmill
physical activity 15 minutes/day
weight-bearing treadmill, pulsereserve increase of 50 %
High Dose Training
2x 30 minutes/day on a weight-bearing treadmill
physical activity, 2 x 30 minutes/day
weight-bearing treadmill, pulsereserve increase of 50 %
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical activity 15 minutes/day
weight-bearing treadmill, pulsereserve increase of 50 %
physical activity, 2 x 30 minutes/day
weight-bearing treadmill, pulsereserve increase of 50 %
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 18 years
* first stroke or only minor invalidity from previous strokes (mRS 0-2)
* truncal stability
* SSS \< 58
Exclusion Criteria
* debut of symptoms \> 48 h prior to admission
* consent not given \< 24 h of admission
* pregnancy or lactation
* isolation
* blood sampling generally not possible
* allergy due to accelerometer wear
* ulcers or other skin diseases in the area of accelerometer placement
* unstable cardiologic condition (AMI etc.)
* acute high and sustained resting systolic blood pressure where treatment is necessary
* acute heart rhythm disorder where treatment is necessary
* unable to cooperate
* significant orthopedic conditions (fractures etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillerod Hospital, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Maria Strømmen
clinical assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillerød Hospital
Hillerød, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30704 part 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.